Abbott Laboratories Acquires Evalve for $410,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b114fb31-c177-4446-8e9d-b740bbf192fd&Preview=1
Date
9/11/2009
Company Name
Evalve
Mailing Address
4045 Campbell Ave Menlo Park, CA 94025
Company Description
Evalve, Inc. is a leader in innovative devices for the endovascular repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options.
Website
http://www.evalveinc.com
Transaction Type
M&A
Transaction Amount
$410,000,000
Transaction Round
Proceeds Purposes
M&A Terms
The deal includes a $320 million up-front payment, plus another $90 million in possible earnouts.